Publication:
Dulaglutide slows kidney disease in type 2 diabetes.

Simple item page
dc.contributor.authorOliva-Damaso, Nestor
dc.contributor.authorOliva-Damaso, Elena
dc.contributor.authorPayan, Juan
dc.contributor.authorPorrini, Esteban
dc.date.accessioned2023-02-08T14:41:53Z
dc.date.available2023-02-08T14:41:53Z
dc.date.issued2020
dc.identifier.doi10.1016/S0140-6736(19)32550-4
dc.identifier.essn1474-547X
dc.identifier.pmid32087784
dc.identifier.unpaywallURLhttp://www.thelancet.com/article/S0140673619325504/pdf
dc.identifier.urihttp://hdl.handle.net/10668/15149
dc.issue.number10224
dc.journal.titleLancet (London, England)
dc.journal.titleabbreviationLancet
dc.language.isoen
dc.organizationHospital Costa del Sol
dc.page.number559
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshGlucagon-Like Peptides
dc.subject.meshHumans
dc.subject.meshImmunoglobulin Fc Fragments
dc.subject.meshKidney Diseases
dc.subject.meshRecombinant Fusion Proteins
dc.titleDulaglutide slows kidney disease in type 2 diabetes.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number395
dspace.entity.typePublication

Files

Collections

SAS - Hospital Costa del Sol

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía